Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women

被引:83
|
作者
Van Servellen, G
Chang, B
Garcia, L
Lombardi, E
机构
[1] Univ Calif Los Angeles, Sch Nursing, Acute Care Sect, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90095 USA
关键词
D O I
10.1089/10872910260066705
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Antiretroviral treatment nonadherence is complex, implicating more than a patient's ability and motivation to be compliant. The bulk of the research to date focuses on individual level barriers with less emphasis on the many system level factors that potentially impact patients' adherence behaviors. This study examined the effects of system enabling factors in addition to the frequently studied individual predisposing and enabling factors upon nonadherence to treatment. One hundred eighty-two patients from five community-based clinics were interviewed and their medical charts examined. Patients' self-reported nonadherence was correlated with clinicians' assessments of medication and appointment nonadherence. Seven individual predisposing factors (gender, ethnicity, birthplace, years of education, HIV Overview of Problems-Evaluation System [HOPES] psychosocial, Hospital Anxiety and Depression Scale [HADS] anxiety, and HADS depression scores) were found to be significantly associated with treatment adherence/nonadherence. Individual enabling factors (hopefulness and access to health care), as well as treatment by clinic staff, a system enabling factor, were significantly associated with adherence/nonadherence. In a multivariate analysis, six factors-age (younger), gender (female), birth outside the United States, level of hopefulness (lower), access to health care (lower), and treatment by clinic staff (poorer)-accounted for 19.3% of the variance in nonadherence. Results of this study indicated that several individual predisposing and enabling factors were potential predictors of treatment nonadherence; however, system enabling factors, e. g., treatment by clinic staff were also associated with treatment nonadherence. Further studies are needed to examine the complex relationships of individual and system related factors in predicting treatment nonadherence.
引用
收藏
页码:269 / 281
页数:13
相关论文
共 50 条
  • [41] Hospitalization of children born to human immunodeficiency virus-infected women in Europe
    Thorne, C
    Newell, ML
    Dunn, D
    Peckham, C
    Giaquinto, C
    Ruga, E
    Cozzani, S
    DeRossi, A
    DElia, R
    GroschWorner, I
    Mok, J
    Omenaca, F
    GarciaRodriguez, MC
    Bates, I
    deJose, I
    Hawkins, F
    Zapico, RM
    AsensiBotet, F
    Otero, MC
    PerezTamarit, D
    Molina, AG
    Canosa, C
    Scherpbier, H
    Bohlin, AB
    Belfrage, E
    Levy, J
    Alimenti, A
    Ferrazin, A
    DeMaria, A
    Gotta, C
    Mur, A
    Rovira, MT
    Paya, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (12) : 1151 - 1156
  • [42] Codon 215 mutations in human immunodeficiency virus-infected pregnant women
    Kully, C
    Yerly, S
    Erb, P
    Kind, C
    Krautheim, A
    Perrin, L
    Rudin, C
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 705 - 708
  • [43] Prevalence of and associated factors with chronic kidney disease in human immunodeficiency virus-infected patients in Taiwan
    Hsieh, Min-Han
    Lu, Po-Liang
    Kuo, Mei-Chuan
    Lin, Wei-Ru
    Lin, Chun-Yu
    Lai, Chung-Chih
    Tsai, Jih-Jin
    Chen, Tun-Chieh
    Hwang, Shang-Jyh
    Chen, Yen-Hsu
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (03) : 256 - 262
  • [44] Prevalence and Factors Associated With Liver Test Abnormalities Among Human Immunodeficiency Virus-Infected Persons
    Crum-Cianflone, Nancy
    Collins, Gary
    Medina, Sheila
    Asher, Dean
    Campin, Richard
    Bavaro, Mary
    Hale, Braden
    Hames, Charles
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (02) : 183 - 191
  • [45] Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome
    Chirgwin, KD
    Feldman, J
    MuneyyirciDelale, O
    Landesman, S
    Minkoff, H
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (05): : 489 - 494
  • [46] A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women
    Minkoff, H
    Feldman, J
    DeHovitz, J
    Landesman, S
    Burk, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (05) : 982 - 986
  • [47] A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women
    A. Ermel
    P. Tonui
    M. Titus
    Y. Tong
    N. Wong
    J. Ong’echa
    K. Muthoka
    S. Kiptoo
    A. Moormann
    J. Hogan
    A. Mwangi
    S. Cu-Uvin
    P. J. Loehrer
    O. Orang’o
    D. Brown
    BMC Infectious Diseases, 19
  • [48] Where are we now with kidney disease in the human immunodeficiency virus-infected individual?
    Wearne, Nicola
    Okpechi, Ikechi
    Swanepoel, Charles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (08) : 1317 - 1319
  • [49] A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women
    Ermel, A.
    Tonui, P.
    Titus, M.
    Tong, Y.
    Wong, N.
    Ong'echa, J.
    Muthoka, K.
    Kiptoo, S.
    Moormann, A.
    Hogan, J.
    Mwangi, A.
    Cu-Uvin, S.
    Loehrer, P. J.
    Orang'o, O.
    Brown, D.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [50] Prognostic Factors of Human Immunodeficiency Virus-Infected Patients on Chronic Hemodialysis
    Laranjinha, Ivo
    Matias, Patricia Joao
    Dickson, Jorge
    Estibeiro, Herminia
    Boquinhas, Helena
    Barata, Jose Diogo
    BLOOD PURIFICATION, 2017, 44 (03) : 244 - 250